[Federal Register Volume 78, Number 20 (Wednesday, January 30, 2013)]
[Notices]
[Page 6329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-01978]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Cooperative Research 
Agreements Related to the World Trade Center Health Program (U01) PAR 
12-126, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8:00 a.m.-5:00 p.m., March 5, 2013 (Closed).
    Place: CDC, Roybal Campus, Building 19 (Global Communications 
Center), Rooms 245/246, Atlanta, Georgia 30333, Telephone: (404) 
639-4800.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Cooperative Research Agreements Related to the World 
Trade Center Health Program (U01) PAR 12-126.''
    Contact Person for More Information: Nina Turner, Ph.D., 
Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop 
G800, Morgantown, West Virginia 26505, Telephone: (304) 285-5976.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-01978 Filed 1-29-13; 8:45 am]
BILLING CODE 4163-18-P